Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: A role in nerve cell death?

被引:124
作者
MouattPrigent, A [1 ]
Karlsson, JO [1 ]
Agid, Y [1 ]
Hirsch, EC [1 ]
机构
[1] GOTHENBURG UNIV, INST NEUROBIOL, S-40033 GOTHENBURG, SWEDEN
关键词
dopamine; calcium; cell death; substantia nigra; parkinsonism; protease;
D O I
10.1016/0306-4522(96)00100-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease is characterized by the lass of dopaminergic neurons in the substantia nigra and, to a lesser extent, the ventral tegmental area and catecholaminergic cell group A8. However, among these dopaminergic neurons, those expressing the calcium buffering protein calbindin are selectively preserved, suggesting that a rise in intracellular calcium concentrations may be involved in the cascade of events leading to nerve cell death in Parkinson's disease. We therefore analysed immunohistochemically the expression of the calcium-dependent protease calpain II (m-calpain) in the mesencephalon of patients with Parkinson's disease, progressive supranuclear palsy or striatonigral degeneration, where nigral dopaminergic neurons degenerate, and matched controls without nigral involvement. Calpain immunoreactivity was found in fibers and neuronal perikarya in the substantia nigra, the ventral tegmental area, catecholaminergic cell group A8 and the locus coeruleus. In patients with Parkinson's disease but not with the other neurodegenerative disorders, m-calpain immunoreactivity was detected in fibers with an abnormal morphology and in Lewy bodies. Sequential double staining revealed that most of these m-calpain-positive fibers and neuronal perikarya co-expressed tyrosine hydroxylase, indicating that most m-calpain neurons are catecholaminergic. Quantitative analysis of m-calpain staining in the substantia nigra and locus coeruleus revealed an increased density of fibers and neuronal perikarya in parkinsonian patients in both structures. These data suggest that increased calcium concentrations may be associated with nerve cell death in Parkinson's disease. Copyright (C) 1996 IBRO.
引用
收藏
页码:979 / 987
页数:9
相关论文
共 51 条
[1]   HIGH-LEVELS OF C-REL EXPRESSION ARE ASSOCIATED WITH PROGRAMMED CELL-DEATH IN THE DEVELOPING AVIAN EMBRYO AND IN BONE-MARROW CELLS IN-VITRO [J].
ABBADIE, C ;
KABRUN, N ;
BOUALI, F ;
SMARDOVA, J ;
STEHELIN, D ;
VANDENBUNDER, B ;
ENRIETTO, PJ .
CELL, 1993, 75 (05) :899-912
[2]  
Anglade P., 1995, Society for Neuroscience Abstracts, V21, P1250
[3]  
[Anonymous], PROGR SUPRANUCLEAR P
[4]   CALPAIN AND CALPASTATIN LEVELS IN DIFFERENT ORGANS OF THE RABBIT [J].
BLOMGREN, K ;
NILSSON, E ;
KARLSSON, JO .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1989, 93 (02) :403-407
[5]   DEVELOPMENTAL-CHANGES OF CALPAIN AND CALPASTATIN IN RABBIT BRAIN [J].
BLOMGREN, K ;
KARLSSON, JO .
NEUROCHEMICAL RESEARCH, 1989, 14 (11) :1149-1152
[6]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[7]   [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY [J].
BOKOBZA, B ;
RUBERG, M ;
SCATTON, B ;
JAVOYAGID, F ;
AGID, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) :167-175
[8]   TYROSINE HYDROXYLASE-LIKE IMMUNOREACTIVITY IN SENILE PLAQUES IS NOT RELATED TO THE DENSITY OF TYROSINE HYDROXYLASE-POSITIVE FIBERS IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
CERVERA, P ;
DUYCKAERTS, C ;
RUBERG, M ;
HIRSCH, E ;
RANSMAYR, G ;
HAUW, JJ ;
AGID, Y .
NEUROSCIENCE LETTERS, 1990, 110 (1-2) :210-215
[9]   GLUTATHIONE-PEROXIDASE, GLIAL-CELLS AND PARKINSONS-DISEASE [J].
DAMIER, P ;
HIRSCH, EC ;
ZHANG, P ;
AGID, Y ;
JAVOYAGID, F .
NEUROSCIENCE, 1993, 52 (01) :1-6
[10]   BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE [J].
DEXTER, DT ;
CARTER, CJ ;
WELLS, FR ;
JAVOYAGID, F ;
AGID, Y ;
LEES, A ;
JENNER, P ;
MARSDEN, CD .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :381-389